OTCMKTS:BIOYF BioSyent (BIOYF) Stock Price, News & Analysis → Could Your Accounts Be Frozen? (From Allegiance Gold) (Ad) Free BIOYF Stock Alerts $6.37 +0.04 (+0.63%) (As of 05/3/2024 ET) Add Compare Share Share Today's Range$6.37▼$6.3750-Day Range$6.20▼$6.5152-Week Range$5.26▼$6.97Volume500 shsAverage Volume2,815 shsMarket CapitalizationN/AP/E Ratio31.30Dividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartDividendShort InterestStock AnalysisChartDividendShort Interest Get BioSyent alerts: Email Address Ad Stansberry ResearchGold ManiaFormer Goldman VP Reveals Mysterious "Gold Bank" With Huge Upside Potential He says the gains in this should be far greater than just bullion or mining stocks. Some folks had the chance to see 995% the last time we shared this exact "bank". Most people know nothing about it (except the rich and elite).See his free reveal right here. About BioSyentBioSyent Inc., together with its subsidiaries, acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally. Its products include FeraMAX Pd Therapeutic 150 for the treatment of iron deficiency anemia; FeraMAX Pd Maintenance 45, a chewable supplement for the prevention of iron deficiency anemia; and FeraMAX Pd Powder 15, a powder form product used for preventing iron deficiency and iron deficiency anemia. It offers Tibella, a hormone replacement therapy consisting of tibolone; Inofolic, a natural health product to address polycystic ovarian syndrome symptoms; RepaGyn, a vaginal suppository for the healing of the vaginal mucosa, as well as for the treatment of vaginal dryness caused by aging, menopause, stress, and chemotherapy; and Gelclair, a gel formulated to aid the pain or oral mucositis. In addition, the company provides Cathejell, a lubricant with anesthetic with the indication of lubricating and opening the urethra before the insertion of the catheter; Combogesic to manage mild to moderate acute pain and reduction of fever in adults; and Proktis-M, a rectal suppository for the healing of the anus and rectum. The company sells its products through wholesalers and retail pharmacy chains. The company was formerly known as Hedley Technologies Inc. and changed its name to BioSyent Inc. in June 2006. BioSyent Inc. was founded in 2006 and is headquartered in Mississauga, Canada.Read More BIOYF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart BIOYF Stock News HeadlinesApril 23, 2024 | globenewswire.comBioSyent to Attend Planet MicroCap ShowcaseApril 15, 2024 | globenewswire.comBioSyent Announces Extension of RepaGyn® and Proktis-M® AgreementMay 4, 2024 | InvestorPlace (Ad)$21,000 in profits in six weeks? On Wednesday, May 8, the legendary Jonathan Rose is holding his first ever Masters in Trading Summit. Jonathan is one of the sharpest traders I’ve ever met. He made millions trading in the pits of the world’s largest exchanges.April 10, 2024 | globenewswire.comBioSyent to Present at 2024 Bloom Burton & Co. Healthcare Investor ConferenceApril 1, 2024 | globenewswire.comBioSyent to Present at LD Micro New York Investor ConferenceMarch 27, 2024 | globenewswire.comBioSyent Announces Grant of Restricted Share UnitsMarch 13, 2024 | globenewswire.comBioSyent Releases Financial Results for Fourth Quarter and Full Year 2023March 6, 2024 | globenewswire.comBioSyent Schedules Fourth Quarter and Full Year 2023 Earnings Release for March 13, 2024May 4, 2024 | InvestorPlace (Ad)$21,000 in profits in six weeks? On Wednesday, May 8, the legendary Jonathan Rose is holding his first ever Masters in Trading Summit. Jonathan is one of the sharpest traders I’ve ever met. He made millions trading in the pits of the world’s largest exchanges.March 6, 2024 | globenewswire.comBioSyent Schedules Fourth Quarter and Full Year 2023 Earnings Release for March 13, 2024February 21, 2024 | globenewswire.comBioSyent Named to 2024 TSX Venture 50August 25, 2021 | financialpost.comBioSyent Releases Q2 and H1 2021 Financial ResultsSee More Headlines Receive BIOYF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for BioSyent and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Ex-Dividend for 3/15 Dividend2/28/2024Dividend Payable3/15/2024Today5/04/2024Next Earnings (Estimated)5/24/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A Current SymbolOTCMKTS:BIOYF CUSIPN/A CIKN/A Webwww.biosyent.com Phone(905) 206-0013FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E Ratio31.30 Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Elon Musk's Next MoveWondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.Get This Free Report Key ExecutivesMr. René C. Goehrum (Age 65)Chairman, CEO & President Comp: $387.86kMr. Robert J. MarchVP of Finance & CFOMr. Joost van der MarkVice President of Corporate DevelopmentMs. Neelu AtwalDirector of Human ResourcesMr. Alfred D'SouzaAdvisorKey Competitors1933 IndustriesOTCMKTS:TGIFF4Cable TV InternationalOTCMKTS:CATV4Front VenturesOTCMKTS:FFNTFAB ScienceOTCMKTS:ABSCFAbacus Health ProductsOTCMKTS:ABAHFView All Competitors BIOYF Stock Analysis - Frequently Asked Questions How have BIOYF shares performed in 2024? BioSyent's stock was trading at $6.9619 at the beginning of the year. Since then, BIOYF shares have decreased by 8.5% and is now trading at $6.37. View the best growth stocks for 2024 here. Are investors shorting BioSyent? BioSyent saw a decline in short interest in April. As of April 15th, there was short interest totaling 500 shares, a decline of 83.3% from the March 31st total of 3,000 shares. Based on an average daily volume of 4,700 shares, the days-to-cover ratio is presently 0.1 days. View BioSyent's Short Interest. When is BioSyent's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Friday, May 24th 2024. View our BIOYF earnings forecast. How often does BioSyent pay dividends? What is the dividend yield for BioSyent? BioSyent announced a dividend on Thursday, February 22nd. Shareholders of record on Thursday, February 29th will be paid a dividend of $0.0332 per share on Friday, March 15th. This represents a yield of 2.08%. The ex-dividend date of this dividend is Wednesday, February 28th. This is an increase from the stock's previous dividend of $0.03. Read our dividend analysis for BIOYF. How do I buy shares of BioSyent? Shares of BIOYF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:BIOYF) was last updated on 5/4/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldElon to Transform U.S. Economy? Porter & CompanyAutomatic Income (from home)Awesomely, LLCCould Your Accounts Be Frozen?Allegiance GoldGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchStock-Picking AI Predicts #1 Stock of 2024AltimetryThe A.I. story nobody is telling you (Read ASAP)TradeSmithHave You Seen Elon’s New A.I. Device? (Picture Inside)InvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioSyent Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.